门诊先进疗法的结果暴露患者住院患有严重性结肠炎
Badr Al-Bawardy1,2,3, Eman Al Sulais4, Fatimah AlHarthi5
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Crohn's & colitis 360
|September 22, 2025
概括
以前使用先进疗法 (ATE) 的严重性结肠炎 (UC) 的住院患者的结肠切除率高于先进疗法 (ATN) 的患者. 在UC患者中,低专蛋白水平独立地与切除术风险相关.
科学领域:
- 胃肠病学 胃肠病学
- 临床医学 临床医学
- 炎症性肠道疾病研究研究
背景情况:
- 与历史队伍相比,当代住院的性结肠炎 (UC) 患者可能有不同的先前药物暴露和疾病严重程度.
- 这些不断变化的患者特征对UC结果的临床影响仍然不完全理解.
研究的目的:
- 根据先前的门诊先进治疗暴露 (ATE) 与先进治疗原始 (ATN) 状态,评估严重性结肠炎 (UC) 的住院患者结果.
- 在住院UC患者中识别与切除风险相关的因素.
主要方法:
- 一个多中心的,回顾性研究,涉及成人患者住院治疗严重UC.
- 主要结局:对ATE和ATN组进行比较的胆管切除率.
- 二次结果:住院时间和需要救援医疗治疗.
主要成果:
- 与ATN组 (9%) 相比,ATE组的胆管切除率明显高 (25%) (P < .001).与ATN组相比,ATN组的胆管切除率明显高 (P < .001).
- 住院时间和需要救援医疗的需要在各组之间没有显著差异.
- 胆管切除术与ATE状态,高梅奥内镜子分数,高C反应蛋白,低白蛋白和女性性别有关. 在多变量分析中,低白蛋白是切除术的唯一独立预测因子.
结论:
- 在严重的性结肠炎中,先前的门诊先进治疗暴露与住院期间大肠切除术的风险增加有关.
- 低血清白蛋白是入院UC患者中切除术的独立预测因子.
- 在ATE患者中,切除术率的增加可能表明潜在疾病的严重程度更大,需要进一步调查.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
463
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
463
Inflammatory Bowel Disease V: Surgical Management
455
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
455
Inflammatory Bowel Disease I: Ulcerative Colitis
903
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
903
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
644
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
644
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
439
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
439
Peptic Ulcer Disease IV: Management
439
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
439

